PeptideDB

NSC19630 72835-26-8

NSC19630 72835-26-8

CAS No.: 72835-26-8

MIRA-1 is a maleimide analog. MIRA-1 can cause apoptosis in p53 mutant cells by restoring p53-dependent transcriptional
Data collection:peptidedb@qq.com

This product is for research use only, not for human use. We do not sell to patients.

MIRA-1 is a maleimide analog. MIRA-1 can cause apoptosis in p53 mutant cells by restoring p53-dependent transcriptional transactivation. MIRA-1 has anti-tumor effects.

Physicochemical Properties


Molecular Formula C8H9NO4
Molecular Weight 183.163
Exact Mass 183.053
CAS # 72835-26-8
PubChem CID 227681
Appearance White to light yellow solid powder
Density 1.307g/cm3
Boiling Point 298.2ºC at 760 mmHg
Flash Point 134.1ºC
Index of Refraction 1.514
LogP -0.1
Hydrogen Bond Donor Count 0
Hydrogen Bond Acceptor Count 4
Rotatable Bond Count 4
Heavy Atom Count 13
Complexity 264
Defined Atom Stereocenter Count 0
InChi Key YXEWPGYLMHXLPS-UHFFFAOYSA-N
InChi Code

InChI=1S/C8H9NO4/c1-2-8(12)13-5-9-6(10)3-4-7(9)11/h3-4H,2,5H2,1H3
Chemical Name

(2,5-dioxopyrrol-1-yl)methyl propanoate
Synonyms

NSC 19630; NSC-19630; NSC19630
HS Tariff Code 2934.99.9001
Storage

Powder-20°C 3 years

4°C 2 years

In solvent -80°C 6 months

-20°C 1 month

Shipping Condition Room temperature (This product is stable at ambient temperature for a few days during ordinary shipping and time spent in Customs)

Biological Activity


ln Vitro Saos-2-His273 cells with p53 mutation growth measured by MIRA-1 (25 μM; 48 hr) [1]. Mutant p53 and MIRA-1 (5 μM; 48 hours) both limit cell proliferation [1]. While MIRA-1 (10 μM; 48 hours) much less effectively inhibits p5 3 Saos-2 cells, it dramatically decreases the number of colonies in Saos-2 cells expressing his273 [1]. The fraction of Saos-2 and Saos-2-his273 cells with sub-g1 DNA content increases significantly when mutant p53 is present [1]. MIRA-1 (5 and 10 μM; 24 hours) Transduces SKOV-His175 Cells Cell Proliferation Assay
Cell Assay Cell Proliferation Assay
Cell Types: Saos-2-His273, H1299-His175, SKOV-His175 and SKOV-His273[1]
Tested Concentrations: 25 μM
Incubation Duration: 48 hrs (hours)
Experimental Results: Inhibited cell expression of EGFP, MDM2 and Bax[1]. It grows in a mutant p53-dependent manner, with a survival rate of 18.5~39% without doxycycline and a survival rate of 71.5~87.5% with doxycycline.

Apoptosis analysis
Cell Types: Saos-2 and Saos-2-His273 cells [1]
Tested Concentrations: 10 μM
Incubation Duration: 48 hrs (hours)
Experimental Results: In the presence of the mutant, results in a substantial increase in the fraction of cells with sub-G1 DNA content Section 53 pages.
References

[1]. Reactivation of mutant p53 and induction of apoptosis in human tumor cells by maleimide analogs [published correction appears in J Biol Chem. 2017 Dec 1;292(48):19607]. J Biol Chem. 2005;280(34):30384-30391.


Solubility Data


Solubility (In Vitro) DMSO : ~100 mg/mL (~545.97 mM)
Solubility (In Vivo) Solubility in Formulation 1: ≥ 2.5 mg/mL (13.65 mM) (saturation unknown) in 10% DMSO + 40% PEG300 + 5% Tween80 + 45% Saline (add these co-solvents sequentially from left to right, and one by one), clear solution.
For example, if 1 mL of working solution is to be prepared, you can add 100 μL of 25.0 mg/mL clear DMSO stock solution to 400 μL PEG300 and mix evenly; then add 50 μL Tween-80 to the above solution and mix evenly; then add 450 μL normal saline to adjust the volume to 1 mL.
Preparation of saline: Dissolve 0.9 g of sodium chloride in 100 mL ddH₂ O to obtain a clear solution.

Solubility in Formulation 2: ≥ 2.5 mg/mL (13.65 mM) (saturation unknown) in 10% DMSO + 90% (20% SBE-β-CD in Saline) (add these co-solvents sequentially from left to right, and one by one), clear solution.
For example, if 1 mL of working solution is to be prepared, you can add 100 μL of 25.0 mg/mL clear DMSO stock solution to 900 μL of 20% SBE-β-CD physiological saline solution and mix evenly.
Preparation of 20% SBE-β-CD in Saline (4°C,1 week): Dissolve 2 g SBE-β-CD in 10 mL saline to obtain a clear solution.

Solubility in Formulation 3: ≥ 2.5 mg/mL (13.65 mM) (saturation unknown) in 10% DMSO + 90% Corn Oil (add these co-solvents sequentially from left to right, and one by one), clear solution.
For example, if 1 mL of working solution is to be prepared, you can add 100 μL of 25.0 mg/mL clear DMSO stock solution to 900 μL of corn oil and mix evenly.

 (Please use freshly prepared in vivo formulations for optimal results.)
Preparing Stock Solutions 1 mg 5 mg 10 mg
1 mM 5.4597 mL 27.2985 mL 54.5971 mL
5 mM 1.0919 mL 5.4597 mL 10.9194 mL
10 mM 0.5460 mL 2.7299 mL 5.4597 mL
*Note: Please select an appropriate solvent for the preparation of stock solution based on your experiment needs. For most products, DMSO can be used for preparing stock solutions (e.g. 5 mM, 10 mM, or 20 mM concentration); some products with high aqueous solubility may be dissolved in water directly. Solubility information is available at the above Solubility Data section. Once the stock solution is prepared, aliquot it to routine usage volumes and store at -20°C or -80°C. Avoid repeated freeze and thaw cycles.